NCT00220142View on ClinicalTrials.gov

Molecular Markers of Prognosis in Colorectal Cancer Patients

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

November 30, 2003

Conditions
Colorectal Cancer
Trial Locations (1)

SM2 5PT

Royal Marsden Hospital, Sutton

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER

NCT00220142 - Molecular Markers of Prognosis in Colorectal Cancer Patients | Biotech Hunter | Biotech Hunter